The introduction of fluorine into bioactive molecules is a matter of importance in medicinal chemistry. In this study, representatives of various chemical entities of fluoroaromatic compounds were synthesized. Depending on the reaction conditions, either tetrafluorophthalimides or ammonium tetrafluorophthalamates are accessible from tetrafluorophthalic anhydride and primary amines. Tetrafluorophthalamic acids undergo thermal decarboxylation to yield tetrafluorobenzamides. These could be successfully converted upon treatment with primary amines, in the course of an aromatic nucleophilic substitution, to 2,3,5-trifluorobenzamides with respective amino substituents at the 4-position. The five structure types were characterized by means of spectroscopic and crystallographic methods. The synthesized compounds were evaluated as inhibitors of angiogenesis by measuring microvessel outgrowth in a rat aortic ring assay. The biological activity was maintained throughout these different polyfluorinated chemotypes.
The introduction of fluorine into bioactive molecules is a matter of importance in medicinal chemistry. In this study, representatives of various chemical entities of fluoroaromatic n class="Chemical">compounds were synthesized. Depending on the reaction conditions, either tetrafluorophthalimides or ammonium tetrafluorophthalamates are accessible from tetrafluorophthalic anhydride and primary amines. Tetrafluorophthalamic acids undergo thermal decarboxylation to yield tetrafluorobenzamides. These could be successfully converted upon treatment with primary amines, in the course of an aromatic nucleophilic substitution, to 2,3,5-trifluorobenzamides with respective amino substituents at the 4-position. The five structure types were characterized by means of spectroscopic and crystallographic methods. The synthesized compounds were evaluated as inhibitors of angiogenesis by measuring microvessel outgrowth in a rat aortic ring assay. The biological activity was maintained throughout these different polyfluorinated chemotypes.
Authors: Florencia Zalazar; Paola De Luca; Kevin Gardner; William D Figg; Roberto Meiss; Raul G Spallanzani; Pablo Vallecorsa; Belen Elguero; Javier Cotignola; Elba Vazquez; Adriana De Siervi Journal: Curr Pharm Biotechnol Date: 2015 Impact factor: 2.837
Authors: S Kumar; N Raje; T Hideshima; K Ishitsuka; A Roccaro; N Shiraishi; M Hamasaki; H Yasui; N C Munshi; P Richardson; W D Figg; K C Anderson Journal: Leukemia Date: 2005-07 Impact factor: 11.528
Authors: Anil K Podichetty; Stefan Wagner; Sandra Schröer; Andreas Faust; Michael Schäfers; Otmar Schober; Klaus Kopka; Günter Haufe Journal: J Med Chem Date: 2009-06-11 Impact factor: 7.446
Authors: Christina Therapontos; Lynda Erskine; Erin R Gardner; William D Figg; Neil Vargesson Journal: Proc Natl Acad Sci U S A Date: 2009-05-11 Impact factor: 11.205
Authors: Sylvia S W Ng; Gordon R MacPherson; Michael Gütschow; Kurt Eger; William D Figg Journal: Clin Cancer Res Date: 2004-06-15 Impact factor: 12.531
Authors: Shaunna L Beedie; Chris Mahony; Heather M Walker; Cindy H Chau; William D Figg; Neil Vargesson Journal: Sci Rep Date: 2016-07-22 Impact factor: 4.379
Authors: Christopher Heim; Samuel Maiwald; Christian Steinebach; Matthew K Collins; Jonathan Strope; Cindy H Chau; William D Figg; Michael Gütschow; Marcus D Hartmann Journal: Biochem Biophys Res Commun Date: 2020-12-10 Impact factor: 3.575
Authors: Dorothea M Heuberger; Shefali Harankhedkar; Thomas Morgan; Petra Wolint; Maurizio Calcagni; Barry Lai; Christoph J Fahrni; Johanna Buschmann Journal: Sci Rep Date: 2019-10-01 Impact factor: 4.379
Authors: Megan L Peach; Shaunna L Beedie; Cindy H Chau; Matthew K Collins; Suzana Markolovic; Weiming Luo; David Tweedie; Christian Steinebach; Nigel H Greig; Michael Gütschow; Neil Vargesson; Marc C Nicklaus; William D Figg Journal: Molecules Date: 2020-12-02 Impact factor: 4.411